Citation Impact
Citing Papers
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis
2022 StandoutNobel
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
2010
Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States
2013
Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis
2015
Impact of IL28B gene polymorphisms on interferon- 3 plasma levels during pegylated interferon- /ribavirin therapy for chronic hepatitis C in patients coinfected with HIV
2012
Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial
2011
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells
2010 StandoutNobel
Clinical management of tuberculosis and HIV-1 co-infection
2010
Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis
2013
Antithrombotic Therapy for VTE Disease
2016 Standout
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B -unfavorable genotype patients: Impaired viral kinetics and therapeutic response
2012
IL28B and the Control of Hepatitis C Virus Infection
2010
Can Selected Patients With Newly Diagnosed Pulmonary Embolism Be Safely Treated Without Hospitalization? A Systematic Review
2012
Prevention of VTE in Nonsurgical Patients
2012 Standout
HIV/HCV Co-infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic Technologies
2011
The Course of Posttransplant Hepatitis C Infection
2012
Antithrombotic Therapy for VTE Disease
2012 Standout
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
2014 StandoutNobel
Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management
2015 Standout
Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-α and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients
2012
CD127 Expression, Exhaustion Status and Antigen Specific Proliferation Predict Sustained Virologic Response to IFN in HCV/HIV Co-Infected Individuals
2014
Diagnostic Accuracy of Point-of-Care Tests for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis
2015
Interferon lambdas: the next cytokine storm
2011
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
2011
Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection
2010
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir
2017
Genetics of IL28B and HCV—response to infection and treatment
2012
The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event
2003
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis
2013
Cost-Effectiveness of Enoxaparin as Thromboprophylaxis in Acutely Ill Medical Patients in Spain
2003
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis
2016
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction
2013
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
2014 StandoutNobel
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
2013
Home versus in-patient treatment for deep vein thrombosis
2007
The Immune Response in Tuberculosis
2013 Standout
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
2015 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
Review article: long‐term safety of nucleoside and nucleotide analogues in HBV ‐monoinfected patients
2016
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
2013
Home versus in-patient treatment for deep vein thrombosis
2018
2012
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
Guidelines for the management of hemophilia
2012 Standout
Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort
2013
Works of J. Medraño being referenced
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients
2010
Recurrent Venous Thromboembolism in a Spanish Population
1999
Efectos adversos en la cirugía de la apendicitis aguda
2005
Home treatment of deep venous thrombosis with low molecular weight heparin: Long‐term incidence of recurrent venous thromboembolism
2001
Direct testing of bronchoalveolar lavages from ventilator-associated pneumonia patients
2012
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
2009
Survival of HIV-infected patients with compensated liver cirrhosis
2010
Viral hepatitis and HIV co-infection
2009
Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients Receiving Antiretroviral Therapy
2011
Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV‐Infected and HIV‐Uninfected Patients
2009
Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV
2010
Rate and Predictors of Success in the Retreatment of Chronic Hepatitis C Virus in HIV/Hepatitis C Virus Coinfected Patients With Prior Nonresponse or Relapse
2010
Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis
2014
Mortality of patients infected with HIV in the intensive care unit (2005-2010): significant role of chronic hepatitis C and severe sepsis
2014